アラバマ州における骨髄異形成症候群の臨床試験
アラバマ州内の拠点で、骨髄異形成症候群に関する10件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Alabama at Birmingham Cancer Center, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05564390The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
- University of Alabama at Birmingham, Birmingham
被験者募集中第1相
4 Weeks – 75 Years · 全性別 · 2026/04/13更新 · NCT06047886Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- University of Alabama at Birmingham, Birmingham
被験者募集中第1相
18歳〜75歳 · 全性別 · 2026/03/04更新 · NCT07044544CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
- University of Alabama O'Neal Cancer Center, Birmingham
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/16更新 · NCT05143996SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
被験者募集中第2相
18歳〜75歳 · 全性別 · 2025/10/08更新 · NCT06265584Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
- University of Alabama at Birmingham, Birmingham
被験者募集中第2相
18歳〜60歳 · 全性別 · 2025/10/08更新 · NCT06315309HPC Offered for PRESERVE Expansion
- University of Alabama, Birmingham, Birmingham
被験者募集中観察研究
12歳〜80歳 · 全性別 · 2025/08/28更新 · NCT07145411ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。